Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (114)

2023

  1. Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81

  2. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  3. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  4. Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry

    International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422

  5. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

    Biomedicine and Pharmacotherapy, Vol. 167

  6. Map of use of parenteral analgesic admixtures in Spain. MEDPAIN project

    Farmacia Hospitalaria, Vol. 47, Núm. 4, pp. 161-167

  7. Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

    AIDS Research and Human Retroviruses

  8. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296

  9. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14